Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
GPR183
GPR183 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0081
GPR183 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding GPR183 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0081-LNP
GPR183 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
GM-CSF
GM-CSF Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0082
GM-CSF Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding GM-CSF was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0082-LNP
GM-CSF Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
GM-CSF
GM-CSF Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0083
GM-CSF Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding GM-CSF was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0083-LNP
GM-CSF Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
GM-CSF
GM-CSF Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0084
GM-CSF Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding GM-CSF was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0084-LNP
GM-CSF Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
HSP70
HSP70 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0085
HSP70 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding HSP70 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0085-LNP
HSP70 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
IL-2
IL-2 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0086
IL-2 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding IL-2 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0086-LNP
IL-2 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
OFA-iLRP
OFA-iLRP Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0087
OFA-iLRP Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding OFA-iLRP was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0087-LNP
OFA-iLRP Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
ALDH1A1
ALDH1A1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0088
ALDH1A1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding ALDH1A1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0088-LNP
ALDH1A1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CD40
CD40 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0089
CD40 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CD40 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0089-LNP
CD40 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
TARP peptide
TARP peptide Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0090
TARP peptide Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding TARP peptide was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0090-LNP
TARP peptide Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.213198s